To subscribe to DoubleBlind (starting with Issue 8), click here. If you would like to order copies of our past issues, check out our shop.
As people around the world seek ways to cope with the unique intensity that is the 21st century, we’ve seen the emergence of new and old solutions. Nowhere is that reflected more than in the psychedelic movement. In this issue, we highlight many of the solutions being put forth, from disrupting capitalism to, simply, spending more time with trees. Dr. Bennet Zelner, Associate Professor of Business and Public Policy at the University of Maryland, prompts us to consider what an equitable psychedelic pharma might actually look like (and whether that’s even possible); reporter Ben Adlin investigates the US military’s $27 million psychedelic research program; and DB cofounder Madison Margolin takes us deep into the underground scene of Hasidic Jews, finding catharsis through tripping and praying—at the same time. We also go to Gabon, where Cameroonian poachers are overharvesting Iboga amid a rising demand for Ibogaine, and to an island off of British Columbia, where writer Mercedes Grant encourages us to make space in our lives for grief. The overarching theme is that we’re at a moment that’s calling us inward, to reflect on who we want to be and how we want to show up as the psychedelic “industry” grows. We invite you to contemplate that with us.
(Almost sold out)
We started DoubleBlind two years ago at a time when even the largest magazines and media companies were cutting staff and going out of business. At the time we made a commitment: we will never have a paywall, we will never rely on advertisers we don’t believe in to fund our reporting, and we will always be accessible via email and social media to support people for free on their journeys with plant medicines.
To help us do this, if you feel called and can afford it, we ask you to consider becoming a monthly member and supporting our work. In exchange, you'll receive a subscription to our print magazine, monthly calls with leading psychedelic experts, access to our psychedelic community, and much more.